← Back to Portfolio

Debt Investments Pharmaceuticals Apellis Pharmaceuticals, Inc. First-lien loan ($19,737 par, due 5/2030) Initial Acquisition Date 5/13/2024 Reference Rate and Spread SOFR + 5.75%

public_us

ActivePrivate Credit

Company Type: public_us
Sector: —
Country: US
Headquarters: —
Ticker: APLS
CIK: 1492422

Investment History(2)

Period	Form	Type	Principal	Fair Value	Rate	Status	EDGAR
Dec 31, 2024	10-K	—	—	$159.4M	10.08%	Active	5-021144…
Dec 31, 2024	10-K	—	—	$19.9M	10.08%	Active	5-019845…

Historical Transactions

Sign in to view transactions for this company.

Deal Pipeline

Sign in to view pipeline for this company.

Internal Notes

Sign in to view notes for this company.

Comparables(0)

No comparables found. Pin companies to build your comp set.

Recent SEC Filings(0)

No SEC filings found for this company.

Website Snapshots

Website monitoring coming soon.